Michael Banks, MD, discusses the risk for cirrhosis regression and liver cancer in patients with HCV-related cirrhosis who have already achieved SVR via DAA treatment.
In this video, Anita Afzali, MD, MPH, from The Ohio State University Wexner Medical Center, discusses challenges in the transition from pediatric to adult care in inflammatory bowel disease.
In this video, Gastroenterology Consultant Advisory Board Member David Hudesman, MD, talks about overcoming the challenges associated with the COVID-19 pandemic, how he has been defining urgent and...
In this video, Karen Onel, MD, explains why the ACR's most recent recommendations are needed as well as what new areas they address that had not been included in past guidelines.
